191 related articles for article (PubMed ID: 34423600)
1. Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors.
Kim S; Bok E; Lee S; Lee HJ; Choe Y; Kim NH; Lee WJ; Rho GJ; Lee SL
J Vet Sci; 2021 Sep; 22(5):e62. PubMed ID: 34423600
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of SLUG expression in canine mammary gland tumors and its prognostic significance.
Cheon SB; Kim WH
BMC Vet Res; 2023 Aug; 19(1):112. PubMed ID: 37553661
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel tumour-associated antigens in canine mammary gland tumour.
Furuya M; Funasaki M; Tani H; Sasai K
Vet Comp Oncol; 2015 Sep; 13(3):194-202. PubMed ID: 23510442
[TBL] [Abstract][Full Text] [Related]
4. YRNA and tRNA fragments can differentiate benign from malignant canine mammary gland tumors.
Hasan MN; Rahman MM; Husna AA; Nozaki N; Yamato O; Miura N
Biochem Biophys Res Commun; 2024 Jan; 691():149336. PubMed ID: 38039834
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors.
Kato Y; Asano K; Mogi T; Kutara K; Teshima K; Edamura K; Tsumagari S; Hasegawa A; Tanaka S
J Vet Med Sci; 2007 Jan; 69(1):77-80. PubMed ID: 17283406
[TBL] [Abstract][Full Text] [Related]
6. L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors.
Fukumoto S; Hanazono K; Komatsu T; Iwano H; Kadosawa T; Uchide T
J Vet Med Sci; 2013 May; 75(4):431-7. PubMed ID: 23171689
[TBL] [Abstract][Full Text] [Related]
7. Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours.
Song D; Oh YI; Kim JM; Cheon DS; Kim DY; Seo KW
Vet Med Sci; 2020 Nov; 6(4):958-964. PubMed ID: 32657032
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of canine nm23 cDNAs and their expression in normal and tumor tissues.
Takahashi M; Une R; Fukushima K; Fujiki M; Misumi K; Miyoshi N; Endo Y; Ohishi A; Akuzawa M
J Vet Med Sci; 2005 Aug; 67(8):837-41. PubMed ID: 16141675
[TBL] [Abstract][Full Text] [Related]
9. Usability of serum hedgehog signalling proteins as biomarkers in canine mammary carcinomas.
Koo H; Lee S; Kim WH
BMC Vet Res; 2023 Nov; 19(1):231. PubMed ID: 37932728
[TBL] [Abstract][Full Text] [Related]
10. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
11. Markers of lipid peroxidation and α-tocopherol levels in the blood and neoplastic tissue of dogs with malignant mammary gland tumors.
Karayannopoulou M; Fytianou A; Assaloumidis N; Psalla D; Constantinidis TC; Kaldrymidou E; Koutinas AF
Vet Clin Pathol; 2013 Sep; 42(3):323-8. PubMed ID: 23906434
[TBL] [Abstract][Full Text] [Related]
12. Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target.
Park SY; Baek YB; Lee CH; Kim HJ; Kim HP; Jeon YJ; Song JE; Jung SB; Kim HJ; Moon KS; Park SI; Lee CM; Kim SH
BMC Vet Res; 2024 May; 20(1):233. PubMed ID: 38807154
[TBL] [Abstract][Full Text] [Related]
13. Alteration of somatostatin receptor 2 expression in canine mammary gland tumor.
Sakai K; Yonezawa T; Yamawaki H; Oyamada T
J Vet Med Sci; 2015 Oct; 77(10):1319-22. PubMed ID: 25985817
[TBL] [Abstract][Full Text] [Related]
14. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
16. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.
Huang J; Zhang D; Xie F; Lin D
J Vet Sci; 2015; 16(2):225-31. PubMed ID: 26124697
[TBL] [Abstract][Full Text] [Related]
17. Plasma free amino acid profiles of canine mammary gland tumors.
Azuma K; Osaki T; Tsuka T; Imagawa T; Minami S; Okamoto Y
J Vet Sci; 2012 Dec; 13(4):433-6. PubMed ID: 23271187
[TBL] [Abstract][Full Text] [Related]
18. Relationship between NF-κB expression and malignancy of canine mammary gland tumor tissues.
Mkaouar L; Endo Y; Jun HX; Lee SJ; Jaroensong T; Mochizuki M; Uchida K; Nakayama H; Sasaki N; Nakagawa T
J Vet Med Sci; 2012 Jun; 74(6):713-8. PubMed ID: 22222165
[TBL] [Abstract][Full Text] [Related]
19. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
20. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
